The Boston Globe: Have faster drug approvals led to more dangerous drugs?

  August 11, 2014

 

Newer medications that got the green light from the US Food and Drug Administration had more than a one in four likelihood of receiving a black box warning or being withdrawn from the market within 25 years of their approval. That compares to one in five drugs in 1992, the year Congress passed legislation to allow the FDA to collect pharmaceutical industry fees to speed drug approvals.
continue to read here